1. Goutoudi P, Diza E, Arvanitidou M. Effect of periodontal therapy on crevicular fluid interleukin-1beta and interleukin10 levels in chronic periodontitis. J Dent. 2004;32(7):511-20.
2. Armitage GC. The complete periodontal examination. Periodontol 2000. 2004;34(1):22-33.
3. Taba M, Kinney J, Kim AS, Giannobile WV. Diagnostic biomarkers for oral and periodontal diseases. Dent Clin North Am. 2005;49(3):551-71.
4. Gonçalves Lda R, Soares MR, Nogueira FC, Garcia C, Camisasca DR, Domont G, et al. Comparative proteomic analysis of whole saliva from chronic periodontitis patients. J Proteomics. 2010;73(7):1334–41.
5.Kaufman E, Lamster IB. The diagnostic applications of saliva: a review. Crit Rev Oral Biol Med. 2002;13(2):197-212.
6. Panchbhai AS, Degwekar SS, Bhowte RR. Estimation of salivary glucose, salivary amylase, salivary total protein and salivary flow rate in diabetics in India. J Oral Sci. 2010;52(3):359–68.
7. Callard R, George AJ, Stark J. Cytokines, chaos, and complexity. Immunity. 1999;11(5):507-13.
8. Stashenko P, Fujiyoshi P, Obernesser MS, Prostak L, Haffajee AD, Socransky SS. Levels of interleukin 1 beta in tissue from sites of active periodontal disease. J Clin Periodontol. 1991;18(7):548-54.
9. McFarlane CG, Reynolds JJ, Meikle MC. The release of interleukin-1 beta, tumor necrosis factor-alpha and interferon gamma by cultured peripheral blood mononuclear cells from patients with periodontitis. J Periodontal Res. 1990;25(4):207-14.
10. Kjeldsen M, Holmstrup P, Lindemann RA, Bendtzen K. Bacterial-stimulated cytokine production of peripheral mononuclear cells from patients of various periodontitis categories. J Periodontol. 1995;66(2):139-44.
11. Graves DT. The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction. J Periodontol. 2003;74(3):391-401.
12. Rossomando EF, White L. A novel method for the detection of TNF-alpha in gingival crevicular fluid. J Periodontol. 1993;64(5 Suppl):445-49.
13. Teles RP, Likhari V, Socransky SS, Haffajee AD. Salivary cytokine levels in subjects with chronic periodontitis and in periodontally healthy individuals: A cross-sectional study. J Periodontal Res. 2009;44(3):411-17.
14. Howells GL. Cytokine networks in destructive periodontal disease. Oral Dis. 1995;1(4):266-70.
15. Jiang Y, Magli L, Russo M. Bacterium-dependent induction of cytokines in mononuclear cells and their pathologic consequences in vivo. Infect Immun. 1999;67(5):2125-30.
16. Jandinski JJ, Stashenko P, Feder LS, Leung CC, Peros WJ, Rynar JE et. al. Localization of interleukin-1 beta in human periodontal tissue. J Periodontol. 1991;62:36-43.
17. Ejeil AL, Gaultier F, Igondjo-Tchen S, Senni K, Pellat B, Godeau G et. al. Are cytokines linked to collagen breakdown during periodontal disease progression?. J Periodontol. 2003;74(2):196-201.
18. Alvares O, Klebe R, Grant G, Cochran DL. Growth factor effects on the expression of collagenase and TIMP-1 in periodontal ligament cells. J Periodontol. 1995;66(7):552-28.
19. Nakaya H, Oates TW, Hoang AM, Kamoi K, Cochran DL. Effects of interleukin-1 beta on matrix metalloproteinase-3 levels in human periodontal ligament cells. J Periodontol. 1997;68(6):517-23.
20. Ishihara Y, Nishihara T, Kuroyanagi T, Shirozu N, Yamagishi E, Ohguchi M et. al. Gingival crevicular interleukin-1 and interleukin-1 receptor antagonist levels in periodontally healthy and diseased sites. J Periodontal Res. 1997;32(6):524-29.
21. Hou LT, Liu CM, Liu BY, Lin SJ, Liao CS, Rossomando EF. Interleukin-1beta, clinical parameters and matched cellular-histopathologic changes of biopsied gingival tissue from periodontitis patients. J Periodontal Res. 2003;38(3):247-54.
22. Pushparani DS, Nirmala S. Comparison of acid phosphatase and β D- Glucuronidase enzyme levels in type 2 diabetes mellitus with and without periodontitis. IJSER. 2013;4(10):1164-68.
23. Silness P, Löe H. Periodontal disease in pregnancy II. Acta Odontol Scand. 1964;22:121-26.
24. Löe H, Silness J. Periodontal disease in pregnancy. I. Prevelance and severity. Acta Odontol Scand. 1963;21:533-51.
25. Löe H. The gingival index, the plaque index, and the retention index systems. J Periodontol. 1967;38(6 Suppl):610-16.
26. Ainamo J, Bay I. Problems and proposals for recording gingivitis and plaque. Int Dent J. 1975;25(4):229-35.
27. Newman MG, Taki HH, Klokkevold PR. Caranza FA. Caranza´s clinical periodotology. 10th ed. Missouri: Saunders Elsevier; 2007.
28. Tietz NW. Measurement of total protein - Biuret method. Text book of clinical chemistry. Elseiver Publishers; 2005.
29. Cuggini MA, Haffajee AD, Smith C, Kent RL, Socransky SS. The effect of scaling and root planning on the clinical and microbiological parameters on periodontal diseases. 2000; J Clin Periodontol;27(1):30-36.
30. Aziz HW. The effect of non-surgical periodontal therapy on clinical parameters, salivary and serum melatonin, interleukin-6 levels in chronic periodontitis patients. MSc Thesis. College of Dentistry, Hawler Medical University; 2014.
31. Jalal AA. Effect of local metronidazole gel as an adjunctive therapy to scaling and root planning for chronic periodontitis in male smokers. MSc Thesis. College of Dentistry, Hawler Medical University; 2010.
32. Bollen CM, Mongardini C, Papaioannou W, Van Steenberghe D, Quirynen M. The effect of a one-stage full-mouth disinfection on different intr-oral niches. Clinical and microbiological observations. J Clin Periodontol. 1998;25(1):55-66.
33. Checchi L, Pelliccioni GA. Hand versus ultrasonic instrumentation in the removal of endotoxins from root surfaces in vitro. J Periodontol. 1988;59(6):398-402.
34. Baehni PC, Thilo B, Chapuis B, Pernet D. Effects of Ultrasonic and Sonic Scalers on Dental Plaque Microflora in vitro and in vivo. J Clin Periodontol. 1992;19(7):455-59.
35. Kaufman E, Lamster IB. Analysis of saliva for periodontal diagnosis- a review. J Clin Periodontol. 2000;27(7):453-65.
36. Cobb CM. Non-surgical pocket therapy: mechanical, Ann Periodontol.1996;1(1):443-90.
37. Teshome A, Yitayeh A. The effect of periodontal therapy on glycemic control and fasting plasma glucose level in type 2 diabetic patients: systematic review and meta-analysis. BMC Oral Health. 2016;17(1):31.
38. Sánchez GA, Miozza VA, Delgado A, Busch L. Relationship between salivary mucin or amylase and the periodontal status. Oral Dis. 2013;19(6):585–91.
39. Henskens YM, van den Keijbus PA, Veerman EC, Van der Weijden GA, Timmerman MF, Snoek CM, et al. Protein composition of whole and parotid saliva in healthy and periodontitis subjects: Determination of cystatins, albumin, amylase and IgA. J Periodontal Res. 1996;31(1):57–65.
40. Shaila M, Pai GP, Shetty P. Salivary protein concentration, flow rate, buffering capacity and pH estimation: A comparative study among young and elderly subjects, both normal and with gingivitis and periodontitis. J Indian Soc Periodontol. 2013;17(1):42-46.
41. Frodge BD, Ebersole JL, Kryscio RJ, Thomas MV, Miller CS. Bone remodeling biomarkers of periodontal disease in saliva. J Periodontol. 2008;79(10):1913-19.
42. Passoja A, Puijola I, Knuuttila M, Niemelä O, Karttunen R, Raunio T, et al. Serum levels of interleukin-10 and tumour necrosis factor-α in chronic periodontitis. J Clin Periodontol. 2010;37(10):881-7.
43. Tobón-Arroyave SI, Jaramillo-González PE, Isaza-Guzmán DM. Correlation between salivary IL-1β levels and periodontal clinical status. Arch Oral Biol. 2008;53(4):346-52.
44. Gamonal G, Acevedo A, Bascones A, Jorge O, Silva A. Levels of interleukin-1β, -8, and -10 and RANTES in gingival crevicular fluid and cell populations in adult periodontitis patients and the effect of periodontal tr